Bezafibrate Therapy

Bezafibrate Therapy is a pharmacotherapeutic intervention belonging to the class of fibrates, distinguished by its application in the management of cholestatic liver diseases through the modulation of bile acid metabolism and anti-inflammatory effects mediated via peroxisome proliferator-activated receptor (PPAR) activation.

295

Publications

17.1K

Citations

1.5K

Authors

482

Institutions

Publications per year

2017–2026

34

Authors

1.5K

  1. VB
    Valentina Boyko

    Sheba Medical Center, Israel

    19 publications · 1K citations

    17

    h-index

  2. UG
    Uri Goldbourt

    Sheba Medical Center, Israel

    19 publications · 1.1K citations

    17

    h-index

  3. SB
    Solomon Behar

    Sheba Medical Center, Israel

    20 publications · 1.4K citations

    17

    h-index

  4. DT
    David Tanné

    Sheba Medical Center, Israel

    15 publications · 967 citations

    14

    h-index

  5. MB
    Michal Benderly

    Sheba Medical Center, Israel

    14 publications · 771 citations

    14

    h-index

1–5 of 1.5K

Venues

  1. PubMed

    Repository · 16 publications · 451 citations

    13

    h-index

  2. Atherosclerosis

    15 publications · 497 citations

    13

    h-index

  3. Journal of Lipid Research

    JLR · 8 publications · 426 citations

    8

    h-index

  4. The American Journal of Cardiology

    8 publications · 439 citations

    8

    h-index

  5. Hepatology Research

    8 publications · 415 citations

    8

    h-index

1–5